Advocacy Group Defends Drug Co-Pay Programs As Balancing Marketplace
WASHINGTON, D.C. — Co-pay accumulator programs mitigate the marketing and profits effects drug manufacturers reap from co-pay coupons and return the market to status quo, America’s Health Insurance Plans says in...To view the full article, register now.
Already a subscriber? Click here to view full article